David Rimm

Has grant

Professor

Yale University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Rimm is a Professor at Yale University in the United States. His research focuses on the intersection of artificial intelligence and immunotherapy, particularly in the context of cancer diagnostics and treatment response. He has contributed to significant advancements in understanding biomarkers related to immune checkpoint inhibitors and the role of tumor-infiltrating lymphocytes. Additionally, his work explores the development of companion diagnostic assays and the implications of tissue age on antigenicity.

Recent Grants

Grant: Close

Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer

Open Date: 2020-09-22

Close Date: 2025-06-30

Grant: Close

Exploration and Testing of the Dynamic Range of Phosphor-Integrated Dots and Extension of Potential Application

Open Date: 2019-09-01

Close Date: 2022-03-01

Grant: Close

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer

Open Date: 2015-08-26

Close Date: 2025-07-31

Grant: Close

Measurement of mRNA in Breast Cancer

Open Date: 2015-01-01

Close Date: 2024-01-01

Grant: Close

(PQC2)High-content Pathology with Confocal Microscope Arrays

Open Date: 2013-09-01

Close Date: 2018-06-30

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Rimm

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors

HER2 testing: evolution and update for a companion diagnostic assay

Touching (Proximity) as a Companion Diagnostic Test

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach

Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma

Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma

High-Plex Assessment of Biomarkers in Tumors

Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic Test

An Algorithm as a Biomarker for Response to Immune Checkpoint Inhibitor Therapy

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Spatial characterization and quantification of CD40 expression across cancer types

The Pathologists’ Conundrum

Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review

Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond

Ki67 as a Companion Diagnostic: Good or Bad News?

Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.

Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors

Collaborators (5)

Ke Yuan

Jonathan Warrell

Israa Laklouk

Huy Dinh

Evie H. Carchman

Make your next move.